tradingkey.logo
tradingkey.logo

Intuitive Surgical Inc

ISRG
View Detailed Chart
471.910USD
-6.130-1.28%
Close 03/24, 16:00ETQuotes delayed by 15 min
168.62BMarket Cap
58.97P/E TTM

Intuitive Surgical Inc

471.910
-6.130-1.28%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.28%

5 Days

-2.25%

1 Month

-4.48%

6 Months

+6.29%

Year to Date

-16.68%

1 Year

-7.21%

View Detailed Chart

Key Insights

Intuitive Surgical Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 34 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 610.70.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Intuitive Surgical Inc's Score

Industry at a Glance

Industry Ranking
34 / 209
Overall Ranking
116 / 4547
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

49°C

Very Low
Very High
Positive

Intuitive Surgical Inc Highlights

StrengthsRisks
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 41.28% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 10.06B.
Undervalued
The company’s latest PE is 58.97, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 315.46M shares, decreasing 2.17% quarter-over-quarter.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 518.00 shares of this stock.

Analyst Rating

Based on 36 analysts
Buy
Current Rating
610.697
Target Price
+27.77%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Intuitive Surgical Inc Info

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Ticker SymbolISRG
CompanyIntuitive Surgical Inc
CEORosa (David J)
Websitehttps://www.intuitive.com/en-us/about-us/company
KeyAI